Boston Medical Technologies

Boston Medical Technologies (BMT) is a medical device company specializing in the development and commercialization of non-invasive diagnostic systems for the Autonomic Nervous System (ANS). The company's flagship platform, the ANX 3.0, utilizes patented ANSAR technology to provide a comprehensive assessment of sympathetic and parasympathetic nervous system activity. By integrating Heart Rate Variability (HRV) with respiratory data, the system offers clinicians quantitative insights into autonomic balance, which is critical for managing complex conditions like dysautonomia, diabetic neuropathy, and syncope. BMT’s technology is utilized across various medical specialties, including neurology, cardiology, and pain management, to assist in early diagnosis and treatment optimization. Headquartered in Hudson, Massachusetts, the company provides hardware, software, and clinical support services to healthcare providers and researchers worldwide.